AbCellera

Back to Companies Directory

AbCellera

AbCellera logo

Founded
2012

Technologies

AI Companies (Drug Discovery) Antibody Discovery Companies

AbCellera is a privately held technology company with an antibody discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic. AbCellera's partners include leading biotechnology companies, global health organizations, and many of the top 10 biopharmaceutical companies.

Articles Mentioning This Company

9 Companies Using Artificial Intelligence to Fight Infectious Diseases

Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes from 8-10 years and capitalized R&D costs are reported between ~$1.1B median and ~$2.2B+ per asset in large-pharma cohorts for a new medicine to complete the journey from initial discovery …

13 Publicly Traded AI-driven Drug Discovery Companies

14 Biotechs Utilizing AI-based Research Platforms

According to our internal database, more than 500 life sciences companies in the categories "startups" and "scaleups" are actively using machine learning and deep learning-based predictive and generative capabilities to augment their research strategies in the life sciences, in particular, in drug discovery. Some companies are incorporating AI tools to …

How Big Pharma Adopts AI To Boost Drug Discovery

(Last updated: October 2025) Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from the rise of neural networks in the 1980s to the release of OpenAI’s GPT-3 in 2020, which paved the way for ChatGPT in 2022. Today, AI has become an integral …

10 Companies Applying AI for Biologics Discovery

When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery in the first place. Indeed, as it was captured and analyzed in the report The Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D roughly half of more than 300 analyzed …